|
|
||||||||
Laboratoire de Biologie Vasculaire, Institut de Pharmacologie et de Biologie Structurale du CNRS, 31077 Toulouse Cedex 4, France
1Correspondence: Institut de Pharmacologie et de Biologie Structurale du CNRS, 205 route de Narbonne, 31077 Toulouse Cedex 4, France. E-mail: girard{at}ipbs.fr
Sulfation is a major modification of many molecules in eukaryotes that is dependent on the enzymatic synthesis of an activated sulfate donor, 3'-phosphoadenosine 5'-phosphosulfate (PAPS). While sulfate activation has long been assumed to occur in the cytosol, we show in this study that human PAPS synthetase 1 (PAPSS1), a bifunctional ATP sulfurylase/adenosine 5'-phosphosulfate (APS) kinase enzyme sufficient for PAPS synthesis, accumulates in the nucleus of mammalian cells. Nuclear targeting of the enzyme is mediated by its APS kinase domain and requires a catalytically dispensable 21 amino acid sequence at the amino terminus. Human PAPSS1 and Drosophila melanogaster PAPSS localize to the nucleus in yeast and relieve the methionine auxotrophy of ATP sulfurylase- or APS kinase-deficient strains, suggesting that PAPSS1 is fully functional in vivo when targeted to the nucleus. A second PAPS synthetase gene, designated PAPSS2, has recently been described, mutations of which are responsible for abnormal skeletal development in human spondyloepimetaphyseal dysplasia and murine brachymorphism. We found that PAPSS2, which localizes to the cytoplasm when ectopically expressed in mammalian cells, is relocated to the nucleus when coexpressed with PAPSS1. Taken together, these results indicate that a sulfation pathway might exist in the nucleus of eukaryotic cells.Besset, S., Vincourt, J.-B., Amalric, F., Girard, J.-P. Nuclear localization of PAPS synthetase 1: a sulfate activation pathway in the nucleus of eukaryotic cells.
Key Words: sulfation sulfate activation PAPS synthesis subcellular localization
This article has been cited by other articles:
![]() |
C. Noordam, V. Dhir, J. C. McNelis, F. Schlereth, N. A. Hanley, N. Krone, J. A. Smeitink, R. Smeets, F. C.G.J. Sweep, H. L. C.-v. d. Grinten, et al. Inactivating PAPSS2 Mutations in a Patient with Premature Pubarche N. Engl. J. Med., May 28, 2009; 360(22): 2310 - 2318. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Dick, F. Grondahl, and K. Prydz Overexpression of the 3'-Phosphoadenosine 5'-Phosphosulfate (PAPS) Transporter 1 Increases Sulfation of Chondroitin Sulfate in the Apical Pathway of MDCK II Cells Glycobiology, January 1, 2008; 18(1): 53 - 65. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Alnouti and C. D. Klaassen Tissue Distribution and Ontogeny of Sulfotransferase Enzymes in Mice Toxicol. Sci., October 1, 2006; 93(2): 242 - 255. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Dejima, A. Seko, K. Yamashita, K. Gengyo-Ando, S. Mitani, T. Izumikawa, H. Kitagawa, K. Sugahara, S. Mizuguchi, and K. Nomura Essential Roles of 3'-Phosphoadenosine 5'-Phoshosulfate Synthase in Embryonic and Larval Development of the Nematode Caenorhabditis elegans J. Biol. Chem., April 21, 2006; 281(16): 11431 - 11440. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. G. Brock, Y.-J. Lee, E. Maydanski, T. L. Marburger, M. Luo, R. Paine III, and M. Peters-Golden Nuclear localization of leukotriene A4 hydrolase in type II alveolar epithelial cells in normal and fibrotic lung Am J Physiol Lung Cell Mol Physiol, August 1, 2005; 289(2): L224 - L232. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Yamashita, E. Glasgow, B.-J. Zhang, K. Kusano, and H. Gainer Identification of Cell-Specific Messenger Ribonucleic Acids in Oxytocinergic and Vasopressinergic Magnocellular Neurons in Rat Supraoptic Nucleus by Single-Cell Differential Hybridization Endocrinology, November 1, 2002; 143(11): 4464 - 4476. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Strott Sulfonation and Molecular Action Endocr. Rev., October 1, 2002; 23(5): 703 - 732. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-H. Xu, T. C. Wood, A. A. Adjei, and R. M. Weinshilboum Human 3'-Phosphoadenosine 5'-Phosphosulfate Synthetase: Radiochemical Enzymatic Assay, Biochemical Properties, and Hepatic Variation Drug Metab. Dispos., February 1, 2001; 29(2): 172 - 178. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |